Clover unit Counterpart Health links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients

Reuters
Mar 19
Clover unit Counterpart Health links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients
  • Counterpart Health, a wholly owned subsidiary of Clover Health, released a whitepaper on Counterpart Assistant and flu preventive care in Clover’s Medicare Advantage population.
  • Patients tied to primary care physicians using Counterpart Assistant were 1.39 times more likely to receive a flu vaccination than those in a non-Counterpart Assistant cohort.
  • Providers who completed the in-platform flu insight had patients who were 1.89 times more likely to be vaccinated than those whose providers did not engage with the task.
  • Among COPD patients, association with a Counterpart Assistant-using physician was linked to 17% lower incidence of at least one flu-related acute care event and 22% fewer flu-related acute care encounters.
  • For CHF patients, the same relationship was linked to 11% lower incidence of at least one flu-related acute care event and 18% fewer flu-related acute care encounters.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603190830PRIMZONEFULLFEED9674891) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10